Polarean Imaging Share Discussion Threads

[oapknob1] 19/8/2021 22:46

Couple of quotes from the Final results. The $500million equipment valuation for US alone. Once FDA approval is given this is going Worldwide as countries everywhere will want a better understanding of the effects and treatment for long Covid as well."As we move from research into daily clinical use, we look forward to furthering the global understanding of the COVID-19 medical case by providing the types of quantitative information necessary for fully understanding its mechanisms and post-infection consequences.""With regard to the global COVID-19 pandemic, initial grants have been awarded to several of our users and collaborators in the UK and North America and promising preliminary results are emerging and finding their way into publications. "

[rhatton] 19/8/2021 22:42

Golf east, what’s the current situation with renx? Are they expecting a yay or nay on 26th august?

[goldeast] 19/8/2021 22:35

Perhaps you can see the current volatility with RENX (RNLX) as it approaches its submission date of 26 August. Perhaps the same can happen with POLX.

[gregb] 19/8/2021 21:08

Just out of interest, why are you thinking of investing in October when you think the FDA decision will be delayed until January. Cheers.

[goldeast] 19/8/2021 20:36

Yes, of course. I was open in my message saying it was my feeling, after due research. Nobody knows what the FDA are going to do. The reason I am posting on this BB is that I do believe in POLX and fully intend to invest here again in October.

[gregb] 19/8/2021 07:14

You are correct, this is an investment BB... about a medical company! Let's keep it on topic about POLX. The FDA has not delayed its decision about POLX tech. Fact, not feeling.

[loglorry1] 18/8/2021 21:09

As long as the Renalytx technology works does it matter that it is based on AI technology?

There are many ways to improve patient outcomes. If Richard said this then he should know better.

[goldeast] 18/8/2021 19:53

Yes, but this is an investment BB, not a medical BB.

[gregb] 17/8/2021 22:37

Renx submission based on Artificial intelligence, polx drug/device based on actual physical data. If you are a physician making decisions on a patient which would you prefer to rely on. Richard Houlihen spoke about this in a recent pod cast.

[goldeast] 17/8/2021 19:44

Regarding FDA, I am in RENX, which has been mentioned on this BB. In May 2019, they received breakthrough device designation from the FDA, which gave them the the right to have meetings with FDA to ensure their submission was correct.They made their submission in August 2020. So far they have not received approval. Short term, I expect RENX to get approval, with a consequent surge. My feeling, after researching, is that POLX may get approval in January, as long as Covid is under control and stops diverting FDA resources.

[goldeast] 17/8/2021 19:25

Regarding current weakness, this was a post by Ptolemy on the SHA BB 4 days ago...I have a stock screener to identify island reversals. Slightly different criteria than henry's. Here are today's results on the UK market, daily t/f.tops: GBCH, GBSS,IBLT,CGLN,HAN,WRL,US57,PNIG,CPRA,CIZ,SMLbottoms: CHGB,BMT,JDG,JPE,SKG,LAKE,VNH,VLG,POLX,RAI

[radderssandy] 17/8/2021 18:52

No offence kaka47 but I have read my tea leaves and they say we are in for a big correction back up again :)
May drift a bit before hand………
High conviction share for me, haven’t enjoyed the recent pullback but agree with biddy74, “prices ebb and flow” and we will be much higher when we get closer to FDA approval.

[biddy74] 17/8/2021 15:50

Interesting kaka47 that it took you 3 posts to articulate what could have been done once. Are you trying to talk it down? Nothing scary about it. Prices ebb and flow. I’m holding long term and the current price has no interest to me. Little chance it sees 50p and likely much higher as we move to FDA approval. Traders may sell on news which will provide an opportunity to understand the market post FDA decision.

[kaka47] 17/8/2021 15:18

Justin the clown was only crying the other day about his portfolio getting hammered Fully expecting share price to retest 50p with the markets the way they are chart is looking scary...

[kaka47] 17/8/2021 15:14

Boiler room boys have worked hard to get the share price to where it is but with fully priced up GBP175m valuation and so much execution risk in front of it, share price has run out of steam. share price is in big correction mode

[kaka47] 17/8/2021 15:06

Chart is looking scaryBig correction in share price coming

[moontheloon] 17/8/2021 14:22

Or not... Buying op tho

[moontheloon] 12/8/2021 10:37

Think this is where we will start building to Oct as the fomo's filter in...

[supernumerary] 11/8/2021 23:55

Dr Paul Jordan of Amati Investors talks about Polarean here:

Nothing new, but interesting to hear his views.

[rhatton] 11/8/2021 11:23

You can make a case for high valuations for sure, time will tell.

Maxcyte and renalytix both with the same broker as ours and have recently just listed on Nasdaq. Forecast to be turning their first profit in the next couple of years. I’m not sure what they’re end possibilities are in terms of market place to ours but interesting to compare anyway. Both valued +£700 million.

Polx should according to the broker note be profitable around 2025. So we will face more dilution at some point for sure. But you can make a case for £500 million + market cap in the next couple of years

[loglorry1] 11/8/2021 11:11

I think Justin Waite has a price target more like a gazzilion if that helps? ;-)

It's pretty hard to value but there is no doubt that if they get widespread adoption over the next few years its going to multi-bag seriously from here.

[rhatton] 11/8/2021 09:59

135p currently with several caveats of why it could increase

[moontheloon] 11/8/2021 08:00

What was price target of broker note?

[rhatton] 09/8/2021 13:37

40 fathoms

All good points.

The price per scan is $270 give or take so a gross of around $170 per scan.

Also the recent broker note from Stifel charted out 100 polarisers by 2025 with that year also being the first year of profitability.